Immunological and inflammatory changes after simplifying to dual therapy in virologically suppressed HIV-infected patients through week 96 in a randomized trial
María Trujillo‐Rodríguez, Esperanza Muñoz‐Muela, Ana Serna‐Gallego, Yusnelkis Milanés‐Guisado, Juan Manuel Praena‐Fernández, Ana Isabel Álvarez‐Ríos, Laura Herrera‐Hidalgo, Montserrat Domínguez, Carmen Lozano, Gloria Romero-Vazquez, Cristina Roca-Oporto, Núria Espinosa, Alicia Gutiérrez‐Valencia, Luís F. López‐Cortés
Topics & Concepts
CobicistatTenofovir alafenamideAbacavirMedicineEmtricitabineInternal medicineLamivudineRaltegravirGastroenterologyCD8DolutegravirElvitegravirViral loadRandomized controlled trialRitonavirImmune systemImmunologyAntiretroviral therapyHuman immunodeficiency virus (HIV)VirusHepatitis B virusHIV Research and TreatmentHIV/AIDS drug development and treatmentHIV/AIDS Research and Interventions